| GSE64016 | GSM1562589 | Illumina HiSeq 2500 | Homo sapiens | H1_Exp3.281 | single H1 hESC | cell type: human embryonic stem cells; passages: 30-35; treatment: not sorted |
| GSE64016 | GSM1562854 | Illumina HiSeq 2500 | Homo sapiens | G2_Exp1.076 | single H1-Fucci cell sorted from G2-M phase of the cell cycle only | cell type: human embryonic stem cells; passages: 35-40; treatment: FACS sorted |
| GSE66357 | GSM1620378 | Illumina NextSeq 500 | Homo sapiens | PS034_R2_0_572 | U87 human glioma cells | cell type: U87 human glioma cells |
| GSE66357 | GSM1620634 | Illumina NextSeq 500 | Homo sapiens | PS034_R2_4_253 | MCF10a human breast cancer cells | cell type: MCF10a human breast cancer cells |
| GSE67835 | GSM1657922 | Illumina NextSeq 500 | Homo sapiens | healthy cortex cell 52 | hippocampus OPC | tissue: hippocampus; cell type: OPC; age: postnatal 54 years; c1 chip id: 1772078218; experiment_sample_name: AB_S8 |
| GSE67835 | GSM1658178 | Illumina NextSeq 500 | Homo sapiens | healthy cortex cell 308 | cortex hybrid | tissue: cortex; cell type: hybrid; age: postnatal 21 years; c1 chip id: nochipID8; experiment_sample_name: AB_S7 |
| GSE67980 | GSM1660170 | AB 5500xl Genetic Analyzer | Homo sapiens | Pr21.1.10 | lineage-confirmed PCa CTC CRPC progressed on enzalutamide (Group B) | donor: Pr21; donor type: CRPC; enzalutamide: progressed on enzalutamide (Group B) |
| GSE69405 | GSM1702718 | Illumina HiSeq 2500 | Homo sapiens | LC-PT-45-Re_SC72 | PDX, LC-PT-45-Re | cell type: PDX |
| GSE70580 | GSM1810673 | Illumina HiSeq 2000 | Homo sapiens | T75_P2_C3_ILC3 | Donor T75-tonsil innate lymphoid cell (ILC3) | tonsil donor: Donor T75; facs gating: ILC3; cell type: tonsil Innate lymphoid cells |
| GSE70580 | GSM1810929 | Illumina HiSeq 2000 | Homo sapiens | T86_P1_H12_ILC3 | Donor T86-tonsil innate lymphoid cell (ILC3) | tonsil donor: Donor T86; facs gating: ILC3; cell type: tonsil Innate lymphoid cells |
